The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Summit Therapeutics Inc’s stock clocked out at $18.84, down -14.83% from its previous closing price of $22.12. In other words, the price has decreased by -$14.83 from its previous closing price. On the day, 6.89 million shares were traded.
Ratios:
To gain a deeper understanding of SMMT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.31 and its Current Ratio is at 8.31. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on January 08, 2025, initiated with a Buy rating and assigned the stock a target price of $35.
On December 11, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $30.
On December 06, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $31.Jefferies initiated its Buy rating on December 06, 2024, with a $31 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 27 ’24 when Zanganeh Mahkam bought 54,321 shares for $3.72 per share. The transaction valued at 201,874 led to the insider holds 24,923,800 shares of the business.
Zanganeh Mahkam bought 30,000 shares of SMMT for $112,500 on Mar 26 ’24. The Chief Executive Officer now owns 30,000 shares after completing the transaction at $3.75 per share. On Mar 27 ’24, another insider, Zanganeh Mahkam, who serves as the Chief Executive Officer of the company, bought 26,000 shares for $3.72 each. As a result, the insider paid 96,720 and bolstered with 520,814 shares of the company.
Stock Price History:
Over the past 52 weeks, SMMT has reached a high of $33.89, while it has fallen to a 52-week low of $2.10. The 50-Day Moving Average of the stock is -4.92%, while the 200-Day Moving Average is calculated to be 21.85%.
Shares Statistics:
A total of 737.09M shares are outstanding, with a floating share count of 114.84M. Insiders hold about 84.42% of the company’s shares, while institutions hold 12.62% stake in the company.
